Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 23: The DANPACE II Trial
Author(s): Mads Brix Kronborg Added: 2 years ago
ESC 2023 — Dr Mads Brix Kronborg (Aarhus University Hospital, DE) joins us to discuss the findings from the DANPACE II Trial (NCT00236158). DANPACE II (The DANPACE Investigator Group) trial aimed to compare patients who were randomised in a 1:1 ratio to either a base rate of 60 beats per minute and rate-adaptive DDD (DDDR-60 Group) or a base rate of 40bpm and non-rate adaptive DDD (DDD-40… View more

Electrophysiology & Arrhythmia
TCT 23: PICSO-AMI-I: Pressure Controlled Intermittent Coronary Sinus Occlusion in Acute Myocardial Infarction.
Author(s): Giovanni Luigi Di Maria Added: 2 years ago
TCT 23 - We are joined by Dr Giovanni Luigi Di Maria (John Radcliffe Hospital, UK) to discuss the findings of the PICSO-AMI-I study (NCT04958421), sponsored by Miracor Medical. The PICSO-AMI-I study aimed to assess the safety and feasibility of pressure-controlled intermittent coronary sinus occlusion (PiCSO) in patients with ST-elevation myocardial infarction (MI), presenting with TIMI 0 or 1… View more

Intervention
Author(s): Rasha Al-Lamee , Michael Foley Added: 1 year ago
ACC.24 — Investigators, Dr Rasha K Al-Lamee and Dr Michael Foley (Imperial College London, UK) joined us to discuss the ORBITA COSMIC trial (NCT04892537).This randomized, double-blinded, placebo-controlled trial investigated the effects of coronary sinus reducer (CSR) as compared to placebo on myocardial perfusion via MRI, exercise duration, and symptoms in patients with refractory angina and… View more

Prevention & Chronic Conditions
Semaglutide Modulates Key Pathways to Resolve MASH, Proteomic Analysis Reveals
Added: 7 months ago Source:  Radcliffe CVRM
A new study has explored the underlying mechanisms by which semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), improves outcomes in patients with metabolic dysfunction-associated steatohepatitis (MASH).¹ The research, which combined analysis of a phase 2 clinical trial with preclinical models, identified a unique proteomic signature associated with treatment and suggests that… View more

Cardiovascular Renal Metabolic
High-grade AV Block Due to Lyme Disease
Author(s): Vivek Bhat , Thomas Fretz , Hannah Shideler , et al Added: 1 week ago

Electrophysiology & Arrhythmia
AF Symposium 26: Redo AF Ablation: When to Go Beyond PVI?
Author(s): Boris Schmidt , Atul Verma Added: 4 weeks ago
AF Symposium 2026 - Repeat ablation strategies: Moving Beyond Pulmonary Vein Isolation and the Role of Advanced Mapping.Dr Boris Schmidt (Cardioangiologisches Centrum Bethanien, Frankfurt, DE) and Dr Atul Verma (McGill University Health Centre & McGill University, Montreal, CA, US) discuss optimal approaches to redo atrial fibrillation ablation and the critical decision of when to extend beyond… View more

Electrophysiology & Arrhythmia
EHRA 24: AI-Enabled Single-Lead ECG Can Unmask Conduction Tissue Disease
Author(s): Laurent Fiorina Added: 1 year ago
EHRA 24 - In this short interview, we are joined by Dr Laurent Fiorina (Cardiovascular Institute Paris-Sud (ICPS), FR) joins us to discuss the findings from a clinical investigation into diagnosing conduction tissue disease using an AI-enabled single-lead coronary ECG device.This observational, prospective clinical trial aims to investigate the performance of an artificial intelligence algorithm… View more

Imaging & Diagnostics

Electrophysiology & Arrhythmia
Research Area(s) / Expertise: Job title: Attending Surgeon
José Ramón González Juanatey
Personal History Born in Noia and raised in Santiago de Compostela, Dr José Ramón González Juanatey is one of the most renowned cardiologists in Spain.4 Dr Juanatey is Head of the Cardiology and UCC Service of the Santiago de Compostela University Hospital Complex (CHUS) and Professor of Cardiology at the University of Santiago de Compostela (USC).3 Academic History Dr Juanatey… View more
Anomalous Coronary Artery Origin
Author(s): Luai Madanat , Ahmad Jabri , Michael Gallagher , et al Added: 11 months ago

Imaging & Diagnostics

Prevention & Chronic Conditions